BAKU, Azerbaijan, September 4. Turkmenistan and
UAE-based manufacturer Neopharma LLC discussed prospects for
pharmaceutical cooperation.
This was reflected in a statement published by the Embassy of
Turkmenistan in the UAE following the meeting between Ambassador to
the UAE Bayram Bayramov and representatives of Neopharma LLC in Abu
Dhabi.
“The sides discussed prospects for cooperation in the
pharmaceutical sector, including supplies of high-quality
medicines, exchange of professional experience, technology transfer
and opportunities for developing production capacity,” the
statement said.
According to the information, in the course of the meeting, the
sides agreed to continue dialogue on the discussed areas of
cooperation, including through establishing contacts with
Turkmenistan's Ministry of Health and Medical Industry.
Founded in 2003, Neopharma is one of the UAE's leading
pharmaceutical manufacturers. The company operates 10 manufacturing
facilities across three continents, supplies medicines to more than
50 international markets, and has manufacturing partnerships with
global pharmaceutical companies, including Pfizer and Merck.
Earlier, in December 2025, UAE Ambassador to Turkmenistan Ahmet
Al-Khay Khamad Al-Hammeli expressed his country’s willingness to
double the trade turnover between the two countries in the coming
years.
The UAE’s economic presence in Turkmenistan extends beyond
trade, with Emirati energy companies playing a major role in the
country’s oil and gas sector. Dragon Oil has operated in
Turkmenistan for 25 years, while ADNOC’s international investment
arm XRG is involved in Offshore Block 1.
